Chemotherapy-Induced Change Clinical Trial
Official title:
The Benefit of Enhanced Day Care of Traditional Chinese Medicine: A Retrospective Study of Medical Records
Verified date | July 2020 |
Source | Taipei City Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
We collected medical records since June 2017 to November 2019., used pair-T test for questionnaire of CTCAE, BFT-I, WHOQOL to evaluate the benefit of enhanced day care of TCM for cancer patients.
Status | Completed |
Enrollment | 401 |
Est. completion date | June 11, 2020 |
Est. primary completion date | June 11, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - The medical records since June 2017 to December 2019 needed to meet the following criterial: (1)age>20 years old, (2)diagnosis meet ICD10:C00.0-C97 (3) needed to do Taiwan brief version of Common Terminology Criteria for Adverse Events Version4.0(Taiwan brief version scale of CTCAE), scale of the Taiwanese Version of the Brief Fatigue Inventory(BFI-T) and scale of the World Health Organization Quality of Life-BREF(WHOQOL-BREF), and those scales needed to be done pretest when patient came to the clinics and posttest when case end. Exclusion Criteria: - The subjects will be excluded if they do not complete pretest and posttest of the following scales:(1) Taiwan brief version scale of CTCAE, (2) BFI-T scale (3) WHOQOL-BREF scale |
Country | Name | City | State |
---|---|---|---|
Taiwan | Taipei city hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
Taipei City Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | scale of Taiwan brief version of Common Terminology Criteria for Adverse Events Version4.0(Taiwan brief version scale of CTCAE) | for chemotherapy related adverse effects in Taiwan | 2020 | |
Secondary | scale of the Taiwanese Version of the Brief Fatigue Inventory(BFI-T) | evaluate the level of fatique | 2020 | |
Secondary | scale of the World Health Organization Quality of Life-BREF(WHOQOL-BREF) | evaluate QOL | 2020 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04122885 -
Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis
|
||
Completed |
NCT04168242 -
Scalp Cooling in Gynecologic Cancer Patients
|
N/A | |
Completed |
NCT04235153 -
CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
|
||
Completed |
NCT04852575 -
ReVital-CORE Program
|
||
Completed |
NCT04554732 -
Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia
|
Early Phase 1 |